Avanos Medical, Inc. · NYSE:AVNS
T. Rowe Price Investment Management, Inc.'s stake in Avanos Medical, Inc. fell to 3.70% (Schedule 13G/A)
Event Apr 30, 2026 · Filed May 7, 2026
T. Rowe Price Investment Management, Inc.'s stake in Avanos Medical, Inc. fell to 3.70%, 1,703,510 shares, as a passive investor on Apr 30, 2026. Filed May 7, 2026 (Schedule 13G/A).
- Stake
- 3.70%
- Shares
- 1,703,510
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 3.70% | 1,703,510 |
Source
Related
- Avanos Medical, Inc.
- T. Rowe Price Investment Management, Inc.
- Avanos Medical, Inc. shareholders
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · May 7, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Oct 7, 2025
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · May 14, 2025
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Feb 14, 2025
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Delgado Sigfrido · Jul 28, 2026
- Form 4 · Galovan Scott Michael · Jul 28, 2026
- Form 4 · Pacitti David · Jul 28, 2026
- Form 4 · Shimer Julie Ann · Jul 28, 2026